REBOXETINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C19H23NO3
Molecular Weight	313.3908
Optical Activity	( + / - )
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of REBOXETINE

Structure Search

SMILES

[H][C@@]1(CNCCO1)[C@H](OC2=CC=CC=C2OCC)C3=CC=CC=C3

InChI

InChIKey=CBQGYUDMJHNJBX-RTBURBONSA-N

InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C19H23NO3
Molecular Weight	313.3908
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:01:47 UTC 2023` Edited by `admin` on `Fri Dec 15 16:01:47 UTC 2023`
Record UNII	947S0YZ36I
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

REBOXETINE

Official Name

English

(±)-(2R*)-2-((.ALPHA.R*)-.ALPHA.-(O-ETHOXYPHENOXY)BENZYL)MORPHOLINE

Common Name

English

REBOXETINE [MI]

Common Name

English

REBOXETINE [HSDB]

Common Name

English

Reboxetine [WHO-DD]

Common Name

English

REBOXITINE

Common Name

English

reboxetine [INN]

Common Name

English

MORPHOLINE, 2-((R)-(2-ETHOXYPHENOXY)PHENYLMETHYL)-, (2R)-REL-

Common Name

English

REBOXETINE [VANDF]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

656118

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

WHO-ATC

N06AX18

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

WHO-VATC

QN06AX18

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

NCI_THESAURUS

C265

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

Code System Code Type Description

EPA CompTox

DTXSID1048257

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

INN

5858

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

PUBCHEM

127151

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

DRUG BANK

DB00234

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

WIKIPEDIA

REBOXETINE

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

MERCK INDEX

m9514

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

Merck Index

ChEMBL

CHEMBL14370

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

SMS_ID

100000078631

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

RXCUI

60842

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

RxNorm

EVMPD

SUB15112MIG

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

MESH

C074679

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

NCI_THESAURUS

C72838

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

CAS

98769-81-4

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

SUPERSEDED

IUPHAR

4808

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

CAS

71620-89-8

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

FDA UNII

947S0YZ36I

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

DRUG CENTRAL

2361

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

LACTMED

Reboxetine

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

HSDB

7701

Created by admin on Fri Dec 15 16:01:47 UTC 2023 , Edited by admin on Fri Dec 15 16:01:47 UTC 2023

PRIMARY

Related Record Type Details


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					L94J81YNNY

REBOXETINE MESYLATE

SALT/SOLVATE -> PARENT

Related Record Type Details


					H9T0KS24ST

DESETHYLREBOXETINE

METABOLITE -> PARENT

Comments:

IN VITRO


					12KO6L8KC6

HYDROXY ESREBOXETINE (4-HYDROXY ETHOXYPHENOXY RING)-

METABOLITE -> PARENT

Comments:

IN VITRO


					T9VO56B0SZ

HYDROXY ESREBOXETINE (5-HYDROXY ETHOXYPHENOXY RING)-

METABOLITE -> PARENT

Comments:

IN VITRO


					MQ2G65486N

HYDROXY REBOXETINE, (R,R)-(4-HYDROXY ETHOXYPHENOXY RING)-

METABOLITE -> PARENT

Comments:

IN VITRO


					Z3B16GH72Q

HYDROXY REBOXETINE, (R,R)-(5-HYDROXY ETHOXYPHENOXY RING)-

METABOLITE -> PARENT

Comments:

IN VITRO

Related Record Type Details


					947S0YZ36I

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Tmax	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC